; The Education and Information Transfer Core (E/IT Core) is structured: 1) To promote the development of AD-related researchers and professional caregivers. 2) To educate family caregivers and the public about AD and our ADCC activities. 3) To provide innovative education and outreach programs to our underserved Latino and American Indian communities. 4) To promote the recruitment of Latino and American Indian research participants, in conjunction with the Clinical Core, including education concerning the value of brain bank donation within the Neuropathology Core. 5) To continue development and updating of our Center Website. 5) To work closely with the Alzheimer's Association Desert Southwest Chapter and other agencies and organizations serving the needs of AD researchers, professional caregivers, patients, and their families. 6) To work closely with other ADCC Cores (including with the Clinical Core in participant recruitment, with the Data Management Core to develop effective procedures to allow tracking of the relationship between educational/outreach efforts and Clinical Core participant enrollment). (7) To collaborate with the Alzheimer Disease Education and Referral Center, with the Education and Information Cores of other ADCs, and with other institutions and organizations in development and evaluation of educational materials. In addition to the continuation of professional and community education efforts that have been successful in the previous funding cycle of our ADCC, newly planned strategies to pursue our goals include: (A) Tracking of former graduate students, post-doctoral fellows, and medical students who have been part of our ADCC professional education programs, regarding AD-related contributions in current positions, publications, and grants;(B) In minority community education/outreach, tracking participation of attendees in Clinical Core, Clinical Trials, and other AD-related research;(C) Development and evaluation of educational materials focused on minority brain bank (Neuropathology Core) participation;(D) Development of a collaborative medical resident education program with the University of Arizona Department of Family and Community Medicine, focusing on AD diagnosis and care of patients from underserved minorities, with evaluation of impact on practice and on referral to ADCC Clinical Core and other AD research projects.
The Arizona Alzheimer's Disease Center's Education and Information Core assists patients and families, professional caregivers, developing researchers, our Latino and Native American communities, and other community stakeholders in the understanding, management and scientific study of Alzheimer's disease. Along the way, it helps the Clinical Core enroll and study our most understudied minority groups in a way that will permits them to capitalize on new developments in the scientific fight against Alzheimer's disease, of the National Institute on Aging.
|Caroli, Anna; Prestia, Annapaola; Wade, Sara et al. (2015) Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI. Alzheimer Dis Assoc Disord 29:101-9|
|Sekar, Shobana; McDonald, Jacquelyn; Cuyugan, Lori et al. (2015) Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes. Neurobiol Aging 36:583-91|
|Ferrari, Raffaele; Ryten, Mina; Simone, Roberto et al. (2014) Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy. Neurobiol Aging 35:1514.e1-12|
|Nugent, Scott; Tremblay, Sebastien; Chen, Kewei W et al. (2014) Brain glucose and acetoacetate metabolism: a comparison of young and older adults. Neurobiol Aging 35:1386-95|
|O'Connor, Mary-Frances; Arizmendi, Brian J (2014) Neuropsychological correlates of complicated grief in older spousally bereaved adults. J Gerontol B Psychol Sci Soc Sci 69:12-8|
|Siderowf, Andrew; Pontecorvo, Michael J; Shill, Holly A et al. (2014) PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders. BMC Neurol 14:79|
|Langbaum, Jessica B; Hendrix, Suzanne B; Ayutyanont, Napatkamon et al. (2014) An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease. Alzheimers Dement 10:666-74|
|Raichlen, David A; Alexander, Gene E (2014) Exercise, APOE genotype, and the evolution of the human lifespan. Trends Neurosci 37:247-55|
|Dugger, Brittany N; Adler, Charles H; Shill, Holly A et al. (2014) Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism Relat Disord 20:525-9|
|Berk, Camryn; Paul, Gaurav; Sabbagh, Marwan (2014) Investigational drugs in Alzheimer's disease: current progress. Expert Opin Investig Drugs 23:837-46|
Showing the most recent 10 out of 325 publications